Terns Pharmaceuticals Inc - ESG Rating & Company Profile powered by AI
Comprehensive Sustainability analysis of Terns Pharmaceuticals Inc can be accessed by signing up for free. Other corporations in the scoring industry group for Terns Pharmaceuticals Inc are displayed below. The ESG rating includes seventeen UN Sustainable Development Goals including: 'Good Health & Wellbeing', 'Climate Action' and 'Life below Water'.
Terns Pharmaceuticals Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.0; made up of an environmental score of 2.7, social score of 3.2 and governance score of 6.0.
4.0
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 989 | Spectrum Pharmaceuticals Inc | 4.1 | High |
| 989 | Tricida Inc | 4.1 | High |
| 1004 | Terns Pharmaceuticals Inc | 4.0 | High |
| 1004 | Can B Corp | 4.0 | High |
| 1004 | CLS Holdings USA Inc | 4.0 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Terns Pharmaceuticals Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Terns Pharmaceuticals Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Terns Pharmaceuticals Inc report the average age of the workforce?
Sign up for free to unlockDoes Terns Pharmaceuticals Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Terns Pharmaceuticals Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Terns Pharmaceuticals Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Terns Pharmaceuticals Inc offer flexible work?
Sign up for free to unlockDoes Terns Pharmaceuticals Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Terns Pharmaceuticals Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Terns Pharmaceuticals Inc conduct supply chain audits?
Sign up for free to unlockDoes Terns Pharmaceuticals Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Terns Pharmaceuticals Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Terns Pharmaceuticals Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Terns Pharmaceuticals Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Terns Pharmaceuticals Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Terns Pharmaceuticals Inc disclose water use targets?
Sign up for free to unlockDoes Terns Pharmaceuticals Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Terns Pharmaceuticals Inc have a product recall in the last two years?
Sign up for free to unlockDoes Terns Pharmaceuticals Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Terns Pharmaceuticals Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Terns Pharmaceuticals Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Terns Pharmaceuticals Inc disclose parental leave metrics?
Sign up for free to unlockDoes Terns Pharmaceuticals Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Terns Pharmaceuticals Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Terns Pharmaceuticals Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Terns Pharmaceuticals Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Terns Pharmaceuticals Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Terns Pharmaceuticals Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Terns Pharmaceuticals Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Terns Pharmaceuticals Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Terns Pharmaceuticals Inc disclose its waste policy?
Sign up for free to unlockDoes Terns Pharmaceuticals Inc report according to TCFD requirements?
Sign up for free to unlockDoes Terns Pharmaceuticals Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Terns Pharmaceuticals Inc disclose energy use targets?
Sign up for free to unlockDoes Terns Pharmaceuticals Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Terns Pharmaceuticals Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Terns Pharmaceuticals Inc
These potential risks are based on the size, segment and geographies of the company.
Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical trial for the treatment of NASH; and TERN-201, a vascular adhesion protein-1 inhibitor that is in Phase Ib clinical trial for the treatment of NASH. It also develops TERN-501, a thyroid hormone receptor beta agonist with enhanced liver distribution and metabolic stability that is in Phase I clinical trial for the treatment of NASH; and TERN-601, a small-molecule Glucagon-Like Peptide-1 receptor agonist program that is intended to orally be administered for NASH and metabolic diseases, such as obesity. The company was incorporated in 2016 and is headquartered in Foster City, California.